Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Wall Street Data Solutions Rating
Neutral
B
Magenta Therapeutics, Inc. Common Stock (MGTA)
Pharmaceutical Preparations
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy. The pipeline of the company includes MGTA-117, MGTA-145, MGTA-45 and others.
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/21/2018
Market Cap
42,441,024
Shares Outstanding
60,670,000
Weighted SO
60,664,697
Total Employees
N/A
Upcoming Earnings
N/A
Similar Tickers
Beta
2.1141
Last Div
0.0000
Range
0.321-1.81
Chg
-0.0587
Avg Vol
247981
Mkt Cap
42441024
Exch
NASDAQ
Country
US
Phone
857 242 0170
DCF Diff
3.2438
DCF
3.7059
Div Yield
0.0000
P/S
0.0000
EV Multiple
3.1481
P/FV
0.0153
Div Yield %
0.0000
P/E
-0.0406
PEG
0.0242
Payout
0.0000
Current Ratio
14.6382
Quick Ratio
14.5568
Cash Ratio
12.0255
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
0.0000
CCC
0.0000
Gross Margin
0.0000
Op Margin
0.0000
Pretax Margin
0.0000
Net Margin
0.0000
Eff Tax Rate
0.0903
ROA
-0.3498
ROE
-0.6171
ROCE
-0.2285
NI/EBT
0.9989
EBT/EBIT
1.6442
EBIT/Rev
0.0000
Debt Ratio
0.0035
D/E
0.0038
LT Debt/Cap
0.0014
Total Debt/Cap
0.0037
Int Coverage
7.0116
CF/Debt
-108.4164
Equity Multi
1.0789
Rec Turnover
0.0000
Pay Turnover
0.0000
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0000
OCF/Share
-18.5925
FCF/Share
-18.7356
Cash/Share
48.5987
OCF/Sales
0.0000
FCF/OCF
1.0077
CF Coverage
-108.4164
ST Coverage
-175.8814
CapEx Coverage
-129.9445
Div&CapEx Cov
-129.9445
P/BV
0.0153
P/B
0.0153
P/S
0.0000
P/E
-0.0406
P/FCF
-0.5798
P/OCF
-0.0376
P/CF
-0.0376
PEG
0.0242
P/S
0.0000
EV Multiple
3.1481
P/FV
0.0153
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Revenue | X | X | X | X | X | 0.00 | 0.00 |
Cost Of Revenue | X | X | X | X | X | 0.00 | 0.00 |
Gross Profit | X | X | X | X | X | 0.00 | 0.00 |
Gross Profit Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | 0.00 |
Research And Development Expenses | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 15.79M | ▼ 7.96M |
General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ 5.94M | ▲ 8.72M |
Selling And Marketing Expenses | X | X | X | X | X | 0.00 | 0.00 |
Selling General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ 5.94M | ▲ 8.72M |
Other Expenses | X | X | X | X | X | 0.00 | 0.00 |
Operating Expenses | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 21.73M | ▼ 16.68M |
Cost And Expenses | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 21.73M | ▼ 16.68M |
Interest Income | XXXXXX | ▲ XXXXXXX | ▼ X | ▲ XXXXXX | ▼ XXXXXX | ▼ -2.89M | ▲ 1.03M |
Interest Expense | X | X | X | X | X | ▼ -2.89M | ▲ 0.00 |
Depreciation And Amortization | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ 466.00K | ▼ 0.00 |
Ebitda | -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -21.27M | ▲ -15.76M |
Ebitda Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | 0.00 |
Operating Income | -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -21.73M | ▲ -15.76M |
Operating Income Ratio | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | 0.00 | 0.00 |
Total Other Income Expenses Net | XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ 1.55M | ▼ 996.00K |
Income Before Tax | -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -20.18M | ▲ -14.76M |
Income Before Tax Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | 0.00 |
Income Tax Expense | XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ 2.89M | ▼ 0.00 |
Net Income | -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -23.06M | ▲ -14.76M |
Net Income Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | 0.00 |
Eps | -X.XX | ▼ -X.XX | ▼ -X.XX | ▲ -X.XX | ▲ -X.XX | ▼ -7.38 | ▲ -3.78 |
Eps Diluted | -X.XX | ▼ -X.XX | ▼ -X.XX | ▲ -X.XX | ▲ -X.XX | ▼ -7.38 | ▲ -3.78 |
Weighted Average Shs Out | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 3.12M | ▲ 3.91M |
Weighted Average Shs Out Dil | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 3.12M | ▲ 3.91M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXXX | ▼ 57.63M | ▲ 157.28M |
Short Term Investments | X | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 54.42M | ▼ 32.59M |
Cash And Short Term Investments | XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 112.04M | ▲ 189.87M |
Net Receivables | X | X | X | X | X | 0.00 | ▲ 519.00K |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Other Current Assets | XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ 3.56M | ▼ 1.06M |
Total Current Assets | XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 115.60M | ▲ 191.45M |
Property Plant Equipment Net | XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ 29.26M | ▼ 893.00K |
Goodwill | X | X | X | X | X | 0.00 | 0.00 |
Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Goodwill And Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Long Term Investments | X | X | X | X | X | 0.00 | 0.00 |
Tax Assets | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Assets | XXXX | ▲ XXXXXXX | XXXXXXX | XXXXXXX | ▲ XXXXXXX | ▼ 1.78M | ▼ 116.00K |
Total Non Current Assets | XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 31.04M | ▼ 1.01M |
Other Assets | X | X | X | X | X | 0.00 | 0.00 |
Total Assets | XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 146.65M | ▲ 192.46M |
Account Payables | XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 2.45M | ▼ 1.37M |
Short Term Debt | X | X | X | X | X | ▲ 3.82M | ▼ 413.00K |
Tax Payables | X | X | X | X | X | 0.00 | 0.00 |
Deferred Revenue | X | X | X | X | X | 0.00 | ▲ 100.00K |
Other Current Liabilities | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ 8.27M | ▲ 11.20M |
Total Current Liabilities | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ 14.55M | ▼ 13.08M |
Long Term Debt | X | X | X | X | X | ▲ 26.14M | ▼ 257.00K |
Deferred Revenue Non Current | X | X | X | X | X | 0.00 | ▲ 745.00K |
Deferred Tax Liabilities Non Current | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Liabilities | X | ▲ XXXXXXX | ▼ X | X | X | 0.00 | 0.00 |
Total Non Current Liabilities | X | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 26.14M | ▼ 1.00M |
Other Liabilities | X | X | X | X | X | 0.00 | 0.00 |
Capital Lease Obligations | X | X | X | X | X | ▲ 29.96M | ▼ 670.00K |
Total Liabilities | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ 40.69M | ▼ 14.08M |
Preferred Stock | XXXXXXXX | ▼ X | X | X | X | 0.00 | 0.00 |
Common Stock | XXXX | ▲ XXXXX | ▲ XXXXX | ▲ XXXXX | ▲ XXXXX | ▲ 61.00K | ▼ 15.00K |
Retained Earnings | -XXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -402.03M | ▲ -78.86M |
Accumulated Other Comprehensive Income Loss | X | ▼ -XXXX | ▲ XXXX | ▼ -XXXXX | ▼ -XXXXX | ▼ -181.00K | ▲ -4.00K |
Other Total Stockholders Equity | XXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 508.11M | ▼ 257.23M |
Total Stockholders Equity | XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 105.96M | ▲ 178.38M |
Total Equity | XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 105.96M | ▲ 178.38M |
Total Liabilities And Stockholders Equity | XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 146.65M | ▲ 192.46M |
Minority Interest | X | X | X | X | X | 0.00 | 0.00 |
Total Liabilities And Total Equity | XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 146.65M | ▲ 192.46M |
Total Investments | X | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 54.42M | ▼ 32.59M |
Total Debt | X | X | X | X | X | ▲ 29.96M | ▼ 670.00K |
Net Debt | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXXX | ▲ -27.66M | ▼ -156.61M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Net Income | -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -20.18M | ▲ -3.28M |
Depreciation And Amortization | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ 466.00K | ▼ 0.00 |
Deferred Income Tax | X | X | X | X | X | 0.00 | 0.00 |
Stock Based Compensation | XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 1.76M | ▼ 416.00K |
Change In Working Capital | -XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▼ 596.00K | ▼ -79.00K |
Accounts Receivables | X | X | X | X | X | 0.00 | 0.00 |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Accounts Payables | -XXXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ -339.00K | ▲ -267.00K |
Other Working Capital | XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ -XXXXXX | ▲ 935.00K | ▼ 188.00K |
Other Non Cash Items | X | ▼ -XXXXXX | ▲ -XXXXXX | ▲ XXXXX | ▲ XXXXX | ▲ 664.00K | ▼ -3.60M |
Net Cash Provided By Operating Activities | -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -16.69M | ▲ -6.54M |
Investments In Property Plant And Equipment | -XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXX | ▼ -XXXXXX | ▲ -XXXXX | ▼ -156.00K | ▲ 0.00 |
Acquisitions Net | X | X | X | X | X | 0.00 | 0.00 |
Purchases Of Investments | X | X | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -9.78M | ▲ 0.00 |
Sales Maturities Of Investments | X | X | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ 25.00M | ▼ 15.00M |
Other Investing Activities | X | ▼ -XXXXXXXX | ▲ X | X | X | ▲ 156.00K | ▲ 3.87M |
Net Cash Used For Investing Activities | -XXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ 15.22M | ▲ 18.87M |
Debt Repayment | X | X | X | X | X | 0.00 | 0.00 |
Common Stock Issued | X | X | X | X | X | ▲ 2.90M | ▼ 0.00 |
Common Stock Repurchased | X | X | X | X | X | ▲ 115.00K | ▲ 49.70M |
Dividends Paid | X | X | X | X | X | 0.00 | 0.00 |
Other Financing Activities | X | ▼ -XXXXXX | ▲ X | ▲ XXXXXXX | ▼ X | ▼ -2.95M | ▼ -49.70M |
Net Cash Used Provided By Financing Activities | X | ▼ -XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ 66.00K | ▲ 49.70M |
Effect Of Forex Changes On Cash | X | X | X | X | X | 0.00 | ▼ -12.33M |
Net Change In Cash | -XXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -1.40M | ▲ 12.33M |
Cash At End Of Period | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXXX | ▼ 59.41M | ▲ 62.63M |
Cash At Beginning Of Period | XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 60.81M | ▼ 50.30M |
Operating Cash Flow | -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -16.69M | ▲ -6.54M |
Capital Expenditure | -XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXX | ▼ -XXXXXX | ▲ -XXXXX | ▼ -156.00K | ▲ 0.00 |
Free Cash Flow | -XXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -16.84M | ▲ -6.54M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Upgrade To Get Access
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Dicta eveniet ex illo maxime minima numquam quibusdam reprehenderit temporibus vel, voluptatum? Delectus eos eveniet id iusto necessitatibus, neque porro unde voluptatibus. Aut blanditiis commodi, iste iure laborum pariatur temporibus. Atque distinctio dolore, doloremque eaque eius harum inventore laudantium quibusdam recusandae voluptatibus.